---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-170137"
form_type: "8-K"
ticker: "GH"
cik: "0001576280"
company_name: "Guardant Health, Inc."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:17:57.374105+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Guardant Health stockholders elect all three director nominees and approve auditor and say-on-pay

## Summary
- Ian Clark, Meghan Joyce, and Samir Kaul elected directors; Clark received 48.4M for, 29.2M withheld.
- Ratification of Deloitte & Touche as auditor: 84.0M for, 26,878 against, 32,392 abstain.
- Advisory vote on executive compensation approved: 66.9M for, 10.5M against, 178,806 abstain.

## SEC filing metadata
- accession: 0001193125-23-170137
- form_type: 8-K
- ticker: GH
- cik: 0001576280
- company_name: Guardant Health, Inc.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1576280/000119312523170137/0001193125-23-170137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1576280/000119312523170137/d495654d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-170137
- JSON: https://secwatch.observer/filing/0001193125-23-170137.json
- Plain text: https://secwatch.observer/filing/0001193125-23-170137.txt

## Key facts
- Shareholder Votes
  Guardant Health, Inc. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Proposal 2 in the Proxy Statement, a proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023, was approved by the following vote: Votes For Votes Against Abstentions 84,048,978 26,878 32,392
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576280/000119312523170137/0001193125-23-170137-index.htm
- Shareholder Votes
  Guardant Health, Inc. shareholders approved Advisory approval of named executive officer compensation at the 2023-06-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, was approved by the following vote: Votes For Votes Against Abstentions Broker Non-Votes 66,909,185 10,481,515 178,806 6,538,742
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576280/000119312523170137/0001193125-23-170137-index.htm
- Shareholder Votes
  Guardant Health, Inc. shareholders approved Election of Directors at the 2023-06-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: All of the nominees for director listed in Proposal 1 in the Company’s Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 27, 2023 (the “ Proxy Statement ”), were elected to serve on the Company’s board of directors by the following vote: Name of Nominee Votes For Votes Withheld Broker Non-Votes Ian Clark 48,391,638 29,177,868 6,538,742 Meghan Joyce 57,913,641 19,655,865 6,538,742 Samir Kaul 76,695,081 874,425 6,538,742
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576280/000119312523170137/0001193125-23-170137-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.